Bolsonaro (center) and Health Minister Pazuello launch national vaccinations plan in December 2020. Photo: Isac Nóbrega/PR
As we explained in today’s Daily Briefing, the Brazilian Health Ministry announced a deal to purchase 20 million doses of Covaxin, the coronavirus vaccine developed by Indian lab Bharat Biotech. The agreement came as part of a strategy to boost vaccination efforts, which have suffered from a serious shortage of inputs and jabs, forcing several cities to momentarily suspend immunization campaigns. The Covaxin deal — valued at BRL 1.6 billion (USD 288 million) — will see doses arrive in Brazil between March and May.
However, according to government sources consulted by The Brazilian Report, there is more to the deal than meets the eye.
The Bharat Biotech purchase took many Health Ministry officials by surprise. Regulators have not signed off on Covaxin and the vaccine is not authorized for use or distribution in the...
The São Paulo City Council on Thursday approved legislation authorizing Brazil’s largest city to sign…
The preliminary report on AI regulations presented to Brazil’s Senate last week provides a middle-of-the-road…
In 2000, Formula 1 great Michael Schumacher had just racked up his 41st race win,…
Overall, the worldwide economic outlook has improved according to the Organization for Economic Co-operation and…
“This is f***ing corruption, it has to change,” protested an irate John Textor, owner of…
Eduardo Leite, governor of the southern Brazilian state of Rio Grande do Sul, on Wednesday…